Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorO'Neill, S.-
dc.contributor.authorSambrook, P.-
dc.contributor.authorDiamond, T.-
dc.contributor.authorEbeling, P.-
dc.contributor.authorFerris, L.-
dc.contributor.authorFlicker, L.-
dc.contributor.authorFindlay, D.-
dc.contributor.authorFiatarone-Singh, M.-
dc.contributor.authorLord, S.-
dc.contributor.authorMacLennan, A.-
dc.contributor.authorMarkwell, A.-
dc.contributor.authorNowson, C.-
dc.contributor.authorPocock, N.-
dc.contributor.authorWilliamson, M.-
dc.identifier.citationAustralian Family Physician, 2002; 31(10):921-928-
dc.descriptionCopyright © 2002 Royal Australian College of General Practitioners Copyright to Australian Family Physician. Reproduced with permission. Permission to reproduce must be sought from the publisher, The Royal Australian College of General Practitioners.-
dc.description.abstractBackground: Osteoporosis Australia has been committed to the education of general practitioners and the community with a series of updated guidelines on the management of osteoporosis. Since the last series was published in Australian Family Physician (August 2000), there have been further advances in our understanding of the treatments involved in both prevention of bone loss and the management of established osteoporosis. Objective: This article represents updated guidelines for the treatment of postmenopausal osteoporosis to assist GPs identify those women at risk and to review current treatment strategies. DISCUSSION: Osteoporosis and its associated problems are major health concerns in Australia, especially with an aging population. While important principles of management are still considered to be maximising peak bone mass and preventing postmenopausal bone loss, new clinical trial data about drugs such as the bisphosphonates, raloxifene and oestrogen have recently become available and the relative role of various agents is gradually becoming clearer. The use of long term hormone replacement therapy has mixed risks and benefits that requires individual patient counselling.-
dc.description.statementofresponsibilityO'Neill Sheila; Sambrook Philip; Diamond Terry; Ebeling Peter; Ferris Linda; Flicker Leon; Findlay David; Singh Maria Fiatarone; Lord Stephen; MacLennan Alastair; Markwell Alex; Nowson Caryl; Pocock Nick; Williamson Margaret-
dc.publisherRoyal Australian College of General Practitioners-
dc.subjectOsteoporosis Australia-
dc.subjectOsteoporosis, Postmenopausal-
dc.subjectRisk Factors-
dc.subjectRisk Reduction Behavior-
dc.subjectFamily Practice-
dc.subjectMiddle Aged-
dc.subjectReferral and Consultation-
dc.subjectCritical Pathways-
dc.titleGuidelines for the treatment of postmenopausal osteoporosis for general practitioners-
dc.typeJournal article-
Appears in Collections:Aurora harvest
Orthopaedics and Trauma publications

Files in This Item:
File Description SizeFormat 
hdl_39778.pdf284.44 kBPublisher's PDFView/Open

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.